Why Artificial Intelligence is the Future of the Biotech Industry

In the next six years, AI’s role in the life sciences is expected to grow by nearly 30%, creating a 5 billion dollar market. Investing in this space early, will allow the technology to develop and return exponentially increasing rewards. The coronavirus pandemic has opened many opportunities for AI in healthcare. However, there are still some hurdles to overcome before AI can be fully integrated into the healthcare system. Future chatbot knowledge systems, such as EIVA, created by LAUNCH!, are addressing these problems.